Recent studies have revealed that certain Alzheimer’s treatments may face obstacles in reaching their intended targets within the brain, raising concerns about drug delivery and effectiveness for patients suffering from this neurodegenerative disease.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.